Detailed Information on Publication Record
2021
Global Impact of COVID-19 on Stroke Care and IV Thrombolysis
NOGUEIRA, R. G., M. M. QURESHI, M. ABDALKADER, S. O. MARTINS, H. YAMAGAMI et. al.Basic information
Original name
Global Impact of COVID-19 on Stroke Care and IV Thrombolysis
Authors
NOGUEIRA, R. G., M. M. QURESHI, M. ABDALKADER, S. O. MARTINS, H. YAMAGAMI, Z. M. QIU, O. Y. MANSOUR, A. SATHYA, A. CZLONKOWSKA, G. TSIVGOULIS, D. A. DE SOUSA, J. DEMEESTERE, Robert MIKULÍK (203 Czech Republic, guarantor, belonging to the institution), P. VANACKER, J. E. SIEGLER, J. KORV, J. BILLER, C. W. LIANG, N. S. SANGHA, A. M. ZHA, A. L. CZAP, C. A. HOLMSTEDT, T. N. TURAN, G. NTAIOS, K. MALHOTRA, A. TAYAL, A. LOOCHTAN, A. RANTA, E. A. MISTRY, A. W. ALEXANDROV, D. Y. HUANG, S. YAGHI, E. RAZ, S. A. SHETH, M. H. MOHAMMADEN, M. FRANKEL, E. G. B. LAMOU, H. M. AREF, A. ELBASSIOUNY, F. HASSAN, T. MENECIE, W. MUSTAFA, H. M. SHOKRI, T. ROUSHDY, F. S. SARFO, T. O. ALABI, B. ARABAMBI, E. O. NWAZOR, T. A. SUNMONU, K. WAHAB, J. YARIA, H. H. MOHAMMED, P. B. ADEBAYO, A. D. RIAHI and Sassi S. BEN
Edition
Neurology, Philadelphia, LIPPINCOTT WILLIAMS & WILKINS, 2021, 0028-3878
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30210 Clinical neurology
Country of publisher
United States of America
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 11.800
RIV identification code
RIV/00216224:14110/21:00122752
Organization unit
Faculty of Medicine
UT WoS
000702399700021
Keywords in English
COVID-19; Stroke Care; IV Thrombolysis
Tags
International impact, Reviewed
Změněno: 8/2/2022 10:30, Mgr. Tereza Miškechová
Abstract
V originále
Objective To measure the global impact of COVID-19 pandemic on volumes of IV thrombolysis (IVT), IVT transfers, and stroke hospitalizations over 4 months at the height of the pandemic (March 1 to June 30, 2020) compared with 2 control 4-month periods. Methods We conducted a cross-sectional, observational, retrospective study across 6 continents, 70 countries, and 457 stroke centers. Diagnoses were identified by their ICD-10 codes or classifications in stroke databases. Results There were 91,373 stroke admissions in the 4 months immediately before compared to 80,894 admissions during the pandemic months, representing an 11.5% (95% confidence interval [CI] -11.7 to -11.3, p < 0.0001) decline. There were 13,334 IVT therapies in the 4 months preceding compared to 11,570 procedures during the pandemic, representing a 13.2% (95% CI -13.8 to -12.7, p < 0.0001) drop. Interfacility IVT transfers decreased from 1,337 to 1,178, or an 11.9% decrease (95% CI -13.7 to -10.3, p = 0.001). Recovery of stroke hospitalization volume (9.5%, 95% CI 9.2-9.8, p < 0.0001) was noted over the 2 later (May, June) vs the 2 earlier (March, April) pandemic months. There was a 1.48% stroke rate across 119,967 COVID-19 hospitalizations. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was noted in 3.3% (1,722/52,026) of all stroke admissions. Conclusions The COVID-19 pandemic was associated with a global decline in the volume of stroke hospitalizations, IVT, and interfacility IVT transfers. Primary stroke centers and centers with higher COVID-19 inpatient volumes experienced steeper declines. Recovery of stroke hospitalization was noted in the later pandemic months.
Links
90128, large research infrastructures |
|